Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05981703
What this trial is testing

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorSolid Tumor
BeOne Medicines 337
Testing effectiveness (Phase 2)UnknownNCT04096690
What this trial is testing

Anti-PD-1 Antibody Combined With Pegaspargase in the Treatment of Advanced Stage NK/T-cell Lymphoma

Who this might be right for
Nasal Type Extranodal NK/T-Cell Lymphoma
Ruijin Hospital 22
Early research (Phase 1)Study completedNCT03871959
What this trial is testing

Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma

Who this might be right for
Adenocarcinoma of the PancreasAdenocarcinoma of the ColonAdenocarcinoma of the Rectum
Centre Leon Berard 54
Testing effectiveness (Phase 2)Ended earlyNCT03606174
What this trial is testing

Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaUrothelial Carcinoma BladderUrothelial Carcinoma Ureter+2 more
Mirati Therapeutics Inc. 260
Testing effectiveness (Phase 2)Study completedNCT02834052
What this trial is testing

Pembrolizumab + Poly-ICLC in MRP Colon Cancer

Who this might be right for
Metastatic Colon CancerSolid Tumor
Asha Nayak 42
Early research (Phase 1)UnknownNCT05803928
What this trial is testing

Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies

Who this might be right for
Hepatocellular Carcinoma
Hua Li 70
Testing effectiveness (Phase 2)Looking for participantsNCT06767007
What this trial is testing

SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）

Who this might be right for
Unresectable Locally Recurrent Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 31
Large-scale testing (Phase 3)Active Not RecruitingNCT04379635
What this trial is testing

Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
BeiGene 453
Testing effectiveness (Phase 2)Active Not RecruitingNCT05247684
What this trial is testing

AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC

Who this might be right for
Resectable Non-small Cell Lung Cancer
Akeso 90
Testing effectiveness (Phase 2)UnknownNCT03755115
What this trial is testing

SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Henan Cancer Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT06924606
What this trial is testing

Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy

Who this might be right for
Advanced NSCLC
Shanghai Junshi Bioscience Co., Ltd. 18
Testing effectiveness (Phase 2)UnknownNCT04250948
What this trial is testing

Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancer

Who this might be right for
Gastric CancerLocally Advanced Solid Tumor
Sun Yat-sen University 108
Early research (Phase 1)Looking for participantsNCT05403554
What this trial is testing

NI-1801 in Patients with Mesothelin Expressing Solid Cancers

Who this might be right for
Epithelial Ovarian CancerTriple Negative Breast CancerNon-squamous Non-small-cell Lung Cancer+2 more
Light Chain Bioscience - Novimmune SA 70
Large-scale testing (Phase 3)Looking for participantsNCT06841354
What this trial is testing

Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Who this might be right for
Triple Negative Breast Neoplasms
Merck Sharp & Dohme LLC 1,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07432594
What this trial is testing

Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer

Who this might be right for
High-grade Serous Ovarian Cancer (HGSOC)Fallopian Tube CancersPrimary Peritoneal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 82
Not applicableUnknownNCT05368051
What this trial is testing

Multi-omics Model Predicts Efficacy of Preoperative Neoadjuvant Chemoradiotherapy Combined PD-1 Antibody Therapy for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Neoplasms
Beijing Friendship Hospital 30
Large-scale testing (Phase 3)UnknownNCT03952403
What this trial is testing

HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
CarcinomaNon-Small-Cell Lung
Shanghai Henlius Biotech 643
Testing effectiveness (Phase 2)Looking for participantsNCT07306273
What this trial is testing

IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy

Who this might be right for
Pancreatic Adenocarcinoma Locally Advanced
Ruijin Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04888611
What this trial is testing

Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Huashan Hospital 40
Early research (Phase 1)Study completedNCT03853109
What this trial is testing

AMG 404 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Amgen 171
Next Page